Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Disc Medicine, Inc. (IRON)

Disc Medicine prices $450 million stock offering at $75.00 per share

Mixed Impact 4 of 5 financing Written later

Disc Medicine sold 6,000,000 common shares at $75.00 each, for expected gross proceeds of $450 million, and the offering closed October 22, 2026. The company expects net proceeds of about $422.4 million, which existing shareholders will share with the new investors through dilution, and it says its cash is sufficient into 2030.

Key points

  • Priced 6,000,000 shares at $75.00 per share; expected gross proceeds of $450 million before costs.
  • Underwriters hold a 30-day option for 900,000 more shares; with full exercise, net proceeds would be about $485.9 million.
  • Preliminary unaudited cash, cash equivalents and marketable securities were about $682.8 million as of September 30, 2026.
  • Proceeds are intended for clinical development, bitopertin commercialization for EPP and XLP, and general corporate purposes.

The filing

CompanyDisc Medicine, Inc. (IRON)
Form8-K, current report
Filed with the SECOct 22, 2026, 5:11 PM ET
Accession number0001193125-26-429105

Items reported: 1.01 Material Definitive Agreement2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.